Methotrexate

No definition available.

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries KELA purch., KELA reimb.

Medicine purchases: ATC L01BA01
Medicine purchases: ATC: other data required >3 instances required

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector RX_L01BA01

Extra metadata

First used in FinnGen datafreeze DF4

Summary Statistics

Key figures

All Female Male
Number of individuals 3611 2560 1051
Unadjusted prevalence (%) 1.39 1.74 0.93
Mean age at first event (years) 47.30 46.56 49.09

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.02 1.64 [1.17, 2.31] 4.2e-3 320
15 years 0.01 1.78 [1.32, 2.40] 1.6e-4 215
5 years 0.00 1.84 [1.33, 2.55] 2.5e-4 51
1 year - - - -

Correlations

Index endpoint: RX_L01BA01 – Methotrexate
GWS hits:

Survival analyses between endpoints

Plot

before Methotrexate
after Methotrexate

loading spinner Loading survival analyses plot